Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia (NCT03817502)
A 6-week, International, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of the Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to evaluate the efficacy and safety of cariprazine in the treatment of schizophrenia in the adolescent population.
Who can join: Review the eligibility criteria below.
Location: ProScience Research Group — Culver City, California
Age range: 13 Years to 17 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (57 Sites)
Showing the first 25 of 57 sites.
- ProScience Research Group — Culver City, California
- Atlanta Center for Medical Research — Atlanta, Georgia
- Atlanta Behavioral Research, LLC — Atlanta, Georgia
- Bloomfield Hills MI — Bloomfield Hills, Michigan
- Precise Research Centers — Flowood, Mississippi
- UB Department of Psychiatry — Buffalo, New York
- Manhattan Behavioral Medicine PLLC — New York, New York
- University of Cincinnati — Cincinnati, Ohio
- Family Psychiatry of The Woodlands — The Woodlands, Texas
- Clinic of Child Psychiatry St. Nikolas — Sofia,
- MHAT Targovishte — Targovishte,
- Centro de Investigaciones y Proyectos en Nerurociencia. CIPNA. IPS. SAS. — Barranquilla,
- E.S.E. Hospital Mental de Antioquia — Bello,
- Centro de Investigacion del Sitema Nervioso CISNE — Bogotá,
- Instituto Colombiano Sistema Nervioso Clinica Monserrat — Bogotá,
- Psynapsis Salud Mental SA — Pereira,
- Centro para la Medicina y de Asistencia Medica Especializada S.C. — Culiacán,
- Instituto de Investigacion Clinica AC — Durango,
- Consultorio de Medicina Especializada del Sector Privado — Guadalajara,
- Consultorio Medico En Psiquiatria de Niños y Adolescentes Hospital Aranda de la Parra — Guanajuato City,
- Medical Care and Research S.A. de C.V. — Mérida,
- Iecsi S.C. — Monterrey,
- CIT Neuropsique — Monterrey,
- Instituto de Informacion e Investigacion en Salud Mental AC — Monterrey,
- BLIND Investigaciones SC — San Luis Potosí City,
📞 Contact the Study Coordinator
Phone: (361) 432-6437
Email: RA.ctaRichter@richter.hu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Schizophrenia
- Young Adults With Violent Behavior During Early Psychosis (Aim 2) — New York, New York
- Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia — Toronto, Ontario
- Ketogenic Diet in People With Schizophrenia — Catonsville, Maryland
- Paired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia — Toronto, Ontario
- Investigating the Muscarinic System in Schizophrenia Using Positron Emission Tomography — Toronto, Ontario
- Long-Term Real-World Safety of Cobenfy in Adults With Schizophrenia — Suwanee, Georgia
Explore by condition: All Schizophrenia clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.